Another study showed that overexpression of HDAC5 is related to upregulated CD70, which induces the growth suppression and apoptosis of tumor cells, indicating that targeting HDAC5 may regulate the immune response and affect tumor progression in cancer immunotherapy (56). This evidence concerns the gene HDAC5 and cancer.